A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Clinical trial NCT02464319 · COMPLETED
Trial details
- NCT number
- NCT02464319
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.